2021-01-03,b'$JNJ Great to be invested alongside the pros at JNJ INNOVATION \n\n$FATE iPSC \xf0\x9f\x91\x8d\xf0\x9f\x8f\xbb\n$ARWR RNAi \xf0\x9f\x91\x8d\xf0\x9f\x8f\xbb\n\nBest in class technologies ready to build on the clinical successes of 2010'
2021-01-03,"b""I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the changes at the end of each week in 21'. $VRTX $SRPT $EXAS $CRSP $RARE $ARWR $BBIO $RCKT $EDIT $BLUE $SGMO $QURE $RGNX $FLGT $ZIOP $VYGR $SIOX $ABEO https://t.co/I0ROS0RjAq"""
2021-01-03,"b""@grunmeir @SouthernAB_dom My favorite is $ARWR, see tweet below.\nThey've been executing really well.\n$8B market cap is not small anymore, but the pipeline justifies that valuation.\nStock is volatile, but overall performing greatly.\n\nhttps://t.co/B2Qd9iIvIO"""
2021-01-03,b'$ALRT to divulge ongoing merger talks happening now in New York\nhttps://t.co/fK8PPZ6hwp\n\n$ARWR $WAFD $PKG $CASA $MCO $SRCL $BRKR $BAM $DBD $GAB $HNGR $DCT $TRON $DXCM $ZIOP'
2021-01-02,b'RT @RNAiAnalyst: RNAi Co $SLN has history of providing updates at beginning of year. \n\nThis year could be 1st knockdown data w/ its GalNAc\xe2\x80\xa6'
2021-01-02,"b""RT @kylewdennis: Easy to see why everyone loves Lightning Alerts. Big Money coming in today! $ARWR $ABEO $PACB $BW Let's keep it going @Kei\xe2\x80\xa6"""
2021-01-02,b'RT @RNAiAnalyst: RNAi Co $SLN has history of providing updates at beginning of year. \n\nThis year could be 1st knockdown data w/ its GalNAc\xe2\x80\xa6'
2021-01-02,b'RT @RNAiAnalyst: RNAi Co $SLN has history of providing updates at beginning of year. \n\nThis year could be 1st knockdown data w/ its GalNAc\xe2\x80\xa6'
2021-01-02,b'RT @RNAiAnalyst: RNAi Co $SLN has history of providing updates at beginning of year. \n\nThis year could be 1st knockdown data w/ its GalNAc\xe2\x80\xa6'
2021-01-01,"b""$APPN $ARWR $BCRX $CLSK $KOD $NVAX $SIRC - Year-End 2020 updated results.  Did not catch the tops on most of these but...you get the idea.  Here's to a successful and prosperous 2021! Bests from @MarketTrendAdv! \xf0\x9f\x8d\xbb\xf0\x9f\x8d\xb7 https://t.co/YstM1Tl6Iy"""
2021-01-01,"b'RT @ScalpMaster1: watch $ARWR over 40.75...not a lot of room to move, but nice gap and strong...'"
2021-01-01,b'RNAi Co $SLN has history of providing updates at beginning of year. \n\nThis year could be 1st knockdown data w/ its GalNAc tech+maybe some partnering news. Stock showed strength last few sessions.\n\n$ALNY $ARWR $DRNA'
2021-01-01,"b'@bradloncar Brad, on #2 do you consider $ARWR a Big genomics? Thanks'"
2021-01-01,"b""#401KBeatTheSpy -retirement acc - 401K SDBA gives you lots of flexibility, I like it.\n\n2020: +142.13% - I don't think this is going to last \xf0\x9f\x98\xac\n\nIn order of size $NET $ROKU $NVCR $CRWD $FLGT $BAND $HZNP $PSNL $TDOC $GDRX $ARWR $NARI $ALNY $DDOG $VEEV $GWPH $GBT $BTAI $DRNA $QTNT https://t.co/OwsUgONugx"""
2021-01-01,b'#BeatTheSpy\nPortfolio update - End of 2020\n\n2020: +71.11% / Since 1/1/19:\n+151.39%\n\nLiquidated: ~15% across acc to deploy into school loan \nReduced: $ARWR\nAdded: $ALNY $HZNP\n\nIn order of size $NET $NVCR $ARWR $CRWD $HZNP $FLGT $GWPH $ASND $TDOC $BAND $ALNY $GDRX $AYX $DRNA $QTRX https://t.co/Vlav5rCafS'
2021-01-01,"b'@amarlatif10 $ARWR Not at all. Alny is RNAi pioneer, but a slow orphan and ultra orphan player. I think @ArrowheadPharma is better in selecting the best RNAi triggers, best in bio informatics. Drug candidates have big to very big market potential. A very big biotech company in a few years.'"
2021-01-01,b'RT @BikeRieder: $ARWR A Happy and Healthy 2021 for all my followers and Arrowheadians\xf0\x9f\x8d\x80\xf0\x9f\x8d\x80\xf0\x9f\x8d\x80'
2021-01-01,b'@BikeRieder Happy New Year. Thanks for all the $ARWR coverage in 2020. Looking forward to breaking 10 billion in 2021.'
2021-01-01,b'RT @BikeRieder: $ARWR A Happy and Healthy 2021 for all my followers and Arrowheadians\xf0\x9f\x8d\x80\xf0\x9f\x8d\x80\xf0\x9f\x8d\x80'
2020-12-31,b'$ARWR A Happy and Healthy 2021 for all my followers and Arrowheadians\xf0\x9f\x8d\x80\xf0\x9f\x8d\x80\xf0\x9f\x8d\x80'
2020-12-31,b'New York\xe2\x80\x99s luxury #apartment occupancy has come down notably during the #COVID19 #pandemic.\n\nMore analysis: https://t.co/ec7Zo1dCvQ\n\n#AlternativeData #MachineLearning #ArtificialIntelligence  #RealEstate #Stocks #REO #Foreclosure #Rent #RentRelief $BAM $SPG $LRN $ARWR $UTI $ABEV https://t.co/F0zEjnqXTV'
2020-12-31,b'RT @DavidNohejl: Aaand the final number for year 2020 is 17.69% (TWR). I know everyone and their mom have 100% portfolio returns but whatev\xe2\x80\xa6'
2020-12-31,"b'Aaand the final number for year 2020 is 17.69% (TWR). I know everyone and their mom have 100% portfolio returns but whatever, when I remember March or April, I am really happy with this now.\n\nCurrent portfolio heading into next year:\n$ARWR $TRIL $FSR $AUPH $ONCT $MYOV $SYBX $DIS'"
2020-12-31,b'@pawcio2009 @eagleowl716 Congrats EAGLEOWL716. I got second place with $ARWR( company only) last year and first with $TRIL(company only) this year.  Not to shabby. Congrats to all who made money off this contest this year. Big thanks to Pawcio as well.'
2020-12-31,"b'@IBD_AGatlin @QuanGan00686447 @menosave @IBDinvestors Allison, considering the upfront $300M from Takeda for ARO-AAT and near term milestones for the same, if you follow the revenue recognition template from the ARO-HBV (ie. JNJ-3989) deal, expect revenues to increase in FY2021. $ARWR'"
2020-12-31,"b'2006 jointly Andrew Fire and Craig Mello won Noble Prize for RNA interference. The 1st drug was approved in 2018.  In between there was a rise, collapse, and rise in valuations $ALNY $DRNA $ARWR.  Shall we see the same with CRSPR $CRSP $NTLA $EDIT $BEAM?'"
2020-12-31,"b""@QuanGan00686447 @menosave Yes, I'm a biotech reporter. But @IBDinvestors works hard to make sure we spotlight strong companies from a financial perspective as well as those that are working on earlier-stage technologies. Someone had suggested $ARWR is a CAN SLIM stock and it simply isn't."""
2020-12-31,b'@IBD_AGatlin @menosave It has been odd RNAi has not gotten spotlighted by analysts at large. $ARWR was ranked #1 in the 2020 Deloitte fast 500 for most disruptive tech...Early is best.\n\nhttps://t.co/pytk1tdAxU'
2020-12-31,"b'RT @BikeRieder: $ARWR Biotechs risky to hold through readouts? Yes, small molecules. RNAi? Much better! Look at $ALNY success rate. With Ga\xe2\x80\xa6'"
2020-12-31,b'@3IDWarrant @BikeRieder Actually not surprising given success of the technology. M&amp;A would be prohibitively expensive once a company develops a working platform. $ARWR $ALNY'
2020-12-31,"b'Because of $ARWR, $PAVM &amp; $PDSB this will be my new mode of transportation in 2022 https://t.co/Ipd9siVpaf'"
2020-12-31,"b'@IonisDisrupts @IBD_AGatlin @MarkC53916729 @menosave It will be fun to come back to ""No PIII programs"" at YE20 and count them out at YE21 $ARWR'"
2020-12-31,b'@IBD_AGatlin @MarkC53916729 @menosave $arwr also does not have a drug in phase 3.'
2020-12-31,"b'@IBD_AGatlin @menosave $ions will have a dozen trial updates at min, many unpartnered. $CRSP $EDIT $NTLA $ARKK $AMGN $GMAB $XNCR $MGNX $RHHBY $SGEN $GILD $IMGN $MRSN $ZYME $STRO $ARWR $PFE $BNTX $MRNA $TBIO $ARCT $ILMN $EXAS $GH $biib $azn $pfe $mrna $NTRA $arkg $alny @ARKInvest @CathieDWood @Fidelity'"
2020-12-31,"b""@IBD_AGatlin @MarkC53916729 @menosave Allison, thanks for having $ARWR on your 2021 radar screen.  Financial journalist platforms do a disservice to investors at earnings time, headlining YoY rev and profit changes for precommercial CO's. They are misleading, given the 1x nature of many levers. Thanks and happy 2021."""
2020-12-31,b'$ARWR - How Arrowhead Protects Its Intellectual Property. https://t.co/xJTRyYiDWq  https://t.co/apBk1MM2AH'
2020-12-31,"b""@IBD_AGatlin @menosave Agree 100%, sales are easier to predict as run rate revenue is more stable &amp; easier to predict. That said $ARWR ability to effectively convert a potential drug on several occasions into hundreds of millions demonstrates the value BP puts on #RNAi &amp; ARWR's platform in general."""
2020-12-31,"b'@IBD_AGatlin @menosave 2020 declines were due to YOY comparisons against the booking of 250M from $JNJ for #HBV in 2019, gains return in 2021 as $ARWR recognizes 300M from $TAK for AAT. Another ~400M from TAK in 2021 &amp; additional milestones from $JNJ &amp; $AMGN should maintain growth to commercializations'"
2020-12-31,b'$ARWR ARO-AAT ex-US royalties range from 20-25%.\n\np.s. not bashing $AUPH at all. https://t.co/AfjJcBM52k'
2020-12-31,"b""@menosave That said, there are other companies in this story that aren't CAN SLIM stocks. It's just that RNAi wasn't among the technologies mentioned by experts as being potentially disruptive in 2021. I'm looking forward to what $ARWR, $ALNY and $IONS do next year."""
2020-12-31,"b""@menosave $ARWR is certainly an interesting company. I've written about it numerous times. It's has an RS Rating of 91, which is a good sign, but it's also reporting quarterly losses and declining revenue. Those factors alone would put it out of CAN SLIM rules."""
2020-12-31,b'@BikeRieder Other than $NVS buying Inclisiran for 9.7B there has been no real consolidation in the RNAi space...tons of deals but no M&amp;A...surprising given MOA success $ALNY $ARWR $DRNA $SLN #Platforms'
2020-12-31,"b'RT @BikeRieder: $ARWR Biotechs risky to hold through readouts? Yes, small molecules. RNAi? Much better! Look at $ALNY success rate. With Ga\xe2\x80\xa6'"
2020-12-31,"b'RT @BikeRieder: $ARWR Biotechs risky to hold through readouts? Yes, small molecules. RNAi? Much better! Look at $ALNY success rate. With Ga\xe2\x80\xa6'"
2020-12-31,"b'$ARWR Biotechs risky to hold through readouts? Yes, small molecules. RNAi? Much better! Look at $ALNY success rate. With GalNAc conjugated siRNAs this could be near 100%. This is a Paradigma change. This predictability is of gold value if you\xe2\x80\x99re planning to build a sales force https://t.co/QXNptHBt7E'"
2020-12-31,"b""RT @tanavoi373: @CathieDWood here's a very good article about $ARWR. it mentions their solid patent protection and estimated timelines for\xe2\x80\xa6"""
2020-12-31,"b""@CathieDWood here's a very good article about $ARWR. it mentions their solid patent protection and estimated timelines for when their their rnai therapeutics might hit the market. https://t.co/HFANOTw219"""
2020-12-30,b'RT @portefeuillefun: Time for my #biotech recommendations for 2021.\n\nfrom the larger cap ones:\n$GLPG\n$IONS\n$QURE\n$BNTX\n$ARWR\n$RCKT\n$PRTC\n\na\xe2\x80\xa6'
2020-12-30,b'@ArrowheadPharma shares are a popular gift to give these days $ARWR'
2020-12-30,"b'$ARWR Arrowhead Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/aBzAM5ldGU'"
2020-12-30,b'RT @biostonks: Gene tx players 1-10B mkt cap $NTRA $NVTA $ARWR $FATE $BBIO $IOVA $EDIT $PTCT $PACB $ALLO $NTLA $CDNA $ALKS $RCKT $NSTG $BLU\xe2\x80\xa6'
2020-12-30,b'RT @portefeuillefun: Time for my #biotech recommendations for 2021.\n\nfrom the larger cap ones:\n$GLPG\n$IONS\n$QURE\n$BNTX\n$ARWR\n$RCKT\n$PRTC\n\na\xe2\x80\xa6'
2020-12-30,b'How Arrowhead Protects Its Intellectual Property $arwr  https://t.co/jNiVXkkJPH'
2020-12-30,b'RT @portefeuillefun: Time for my #biotech recommendations for 2021.\n\nfrom the larger cap ones:\n$GLPG\n$IONS\n$QURE\n$BNTX\n$ARWR\n$RCKT\n$PRTC\n\na\xe2\x80\xa6'
2020-12-30,"b'$TKOI OVERSOLD, microscopic float big money loading\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/lbfMVqYawA'"
2020-12-30,b'@Dave59147872 $ARWR At CC Q3 CEO said: at the very end of 2020....'
2020-12-30,"b""$ARWR Near term indicators suggest a minor pullback is likely. ~65 would be my target. But if the bulls remain in control, I wouldn't expect much resistance until $95. Primary target for 2021 remains 130. https://t.co/PY0fRnEjrn"""
2020-12-30,"b'$ARWR and $OCUL are my strongest performing stocks this year, up 198% and 284% respectively. I do not know much about either of them if I\xe2\x80\x99m being honest. This is how 2020 in biotech has been. $XBI'"
2020-12-30,b'Gene tx players 1-10B mkt cap $NTRA $NVTA $ARWR $FATE $BBIO $IOVA $EDIT $PTCT $PACB $ALLO $NTLA $CDNA $ALKS $RCKT $NSTG $BLUE $AGIO $ARCT $SGMO $SRNE $PGEN $RGNX $QURE $DRNA $MYGN $ADVM $FLGT $CLLS $KRYS $PASG\nfeel free to give input https://t.co/ln7esOVk86'
2020-12-30,b'How literal is the word \xe2\x80\x9cat\xe2\x80\x9d in the following  $ARWR statement provided during the 2020 Q4 call? - \xe2\x80\x9cWe are on track to file a CTA for ARO-LUNG2 at the end of this year\xe2\x80\x9d.  Are we to expect a CTA to treat COPD will be filed tomorrow?'
2020-12-30,b'How Arrowhead Protects Its Intellectual Property $ARWR https://t.co/sIEcT3fFzI'
2020-12-30,b'$ARWR - How Arrowhead Protects Its Intellectual Property. https://t.co/p4HmASiDIR #business #trading #finance'
2020-12-30,"b'RT @jonesallen234: mRNA $BNTX, $MRNA, $ARCT, Curevac may be the best flavor for anti-viral/COVID19 in the near term... but RNAi offer the b\xe2\x80\xa6'"
2020-12-30,b'RT @portefeuillefun: Time for my #biotech recommendations for 2021.\n\nfrom the larger cap ones:\n$GLPG\n$IONS\n$QURE\n$BNTX\n$ARWR\n$RCKT\n$PRTC\n\na\xe2\x80\xa6'
2020-12-30,b'RT @portefeuillefun: Time for my #biotech recommendations for 2021.\n\nfrom the larger cap ones:\n$GLPG\n$IONS\n$QURE\n$BNTX\n$ARWR\n$RCKT\n$PRTC\n\na\xe2\x80\xa6'
2020-12-30,b'$ARWR $DRNA $ALNY - next year may be POC in extrahepatic delivery - I will be passing on $ARKG b/c not a single RNAi company in the fund'
2020-12-30,b'Time for my #biotech recommendations for 2021.\n\nfrom the larger cap ones:\n$GLPG\n$IONS\n$QURE\n$BNTX\n$ARWR\n$RCKT\n$PRTC\n\nand from the smaller ones:\n$ETX\n$SLN\n$AFMD\n$WVE\n$SIOX\n\n$IBB $XBI'
2020-12-30,"b'$APPN $ARWR $BCRX $CLSK $FCEL $OSTK $SIRC - For 2021 (and beyond) if you want to be notified immediately of  updates to our Trend Trading analysis or new Trend Trading ideas, be sure to click the bell symbol to turn on @MarketTrendAdv notifications. Good Luck in the New Year!\xf0\x9f\x8d\xb7\xf0\x9f\x8d\xbb https://t.co/qGREZDmtPP'"
2020-12-30,"b""Rose Above Previous Day's High today: $NTP $NMFC $NEW $GRX $BALY $ENTA $MD $ZS $HROW $TARA $CBT $UFS $ARWR $MANH $IAA $CORR $PODD $SAGE $CNQ $FLTR ... https://t.co/TBYRpvrFqi"""
2020-12-30,b'@CathieDWood $ARWR. Please and thanks. @ARKInvest'
2020-12-30,b'$ARWR price movement -3.04 % https://t.co/KziCeCzPpm'
2020-12-30,b'$ARWR Hoping to exit this position at some point . . .   -5.05 % change recently\n https://t.co/skWXzorhUp'
2020-12-30,b'Stocks to watch Dec. 30 thru Dec. 31 $dds $amrs $cyh $expi $arwr $arct $dmrc $gLng $bmi $acy $uuu $rgr $atec $stro $trip $sono $penn $dkng $eLy $ngd $inmd &amp; $BIOL BIOLASE INC. https://t.co/mh9yMraMLE stock tip $BIOL'
2020-12-30,"b'RT @CompoundNovice: 2020 \xe2\x80\x93 when RNA became mainstream\n\nThe vaccines of Moderna, BioNTech and Curevac have brough mRNA into the spotlight.\xe2\x80\xa6'"
2020-12-29,b'Looking forward to 2021 watching $ARWR $TPTX $CRIS $ONCT $ETON $FGEN $APLS $APTO $PHAS $KPTI $ALPN.'
2020-12-29,b'$ARWR expecting -2% by midday. +1.5%-2% by close. Buy early. Buy often. Dry powder is king. Onward and upward.'
2020-12-29,"b""@BrianFeroldi $ARWR their portfolio is so strong and is in a great space..... Also $TSLA well... Just because they're great \xf0\x9f\x92\xb5"""
2020-12-29,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nDirector\n\nDOUGLAS B GIVEN:\n\nhttps://t.co/CiYyyI2Jpj"""
2020-12-29,"b'$ARWR Arrowhead Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/abJAwON7aQ'"
2020-12-29,b'$ARWR Wake me up when we are green .. lol.  \xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd -5.05 % change recently https://t.co/KziCeCzPpm'
2020-12-29,b'$ARWR nice bounce off the 21 EMA\n\nCould build a base around $75 before the next leg up. https://t.co/bPVUuzNaxB'
2020-12-29,b'#Options Flow Stream Update $AMZN $BABA $PYPL $UBER $SNOW $BNTX $ARWR $RIOT $IWM $SPX #OptionsTrading #OptionsFlow #optionstrade #optiontrading #stock #stocks #StockMarket #Investment #investing #invest #investor #investors #UOA https://t.co/I8hjTlEqg3 https://t.co/gRc0fUz2zJ'
2020-12-29,"b'RT @cbuzz247: @ArrowheadPharma From 4th quarter transcript, \xe2\x80\x9c Moving to the future, there is lot you should expect from us during the final\xe2\x80\xa6'"
2020-12-29,"b'Bought 2k $ARWR at $77.5871, now 5k #vssporte shares.'"
2020-12-29,"b'@ArrowheadPharma From 4th quarter transcript, \xe2\x80\x9c Moving to the future, there is lot you should expect from us during the final month of the year and into 2021. Our expectations include the following: one, we are on track to file a CTA for ARO-LUNG2 at the end of this year.\xe2\x80\x9d $ARWR'"
2020-12-29,"b'RT @CompoundNovice: 2020 \xe2\x80\x93 when RNA became mainstream\n\nThe vaccines of Moderna, BioNTech and Curevac have brough mRNA into the spotlight.\xe2\x80\xa6'"
2020-12-29,"b""2020 \xe2\x80\x93 when RNA became mainstream\n\nThe vaccines of Moderna, BioNTech and Curevac have brough mRNA into the spotlight.\n\nCompanies to watch in this space\nmRNA: $BNTX $MRNA $CVAC $ARCT\nsiRNA (RNAi): $ALNY $ARWR $DRNA $SLN\n\nI'm long ARWR, considering ARCT and SLN https://t.co/fc57yC0JxB"""
2020-12-29,b'Recent $ARWR technical alerts: Slingshot Bullish... https://t.co/lcRmua6inZ'
2020-12-29,b'Added a bit of $FATE and $ARWR'
2020-12-29,"b'REVERSALtoDOWN: $ARWR Arrowhead Pharmaceuticals, Inc https://t.co/lkCeeDYNR2 \xf0\x9f\x93\x89 \xf0\x9f\x94\x9c TradeIdeas via \xe2\x9f\xb6 https://t.co/ZgCyz4rX3x'"
2020-12-29,b'RT @Stocktr96494225: $DLOC OVERSOLD! 1 MILLION FLOAT!!!\xf0\x9f\x92\xb8\xf0\x9f\x9b\x92\xf0\x9f\x93\x88\xf0\x9f\x8d\xbe\xe2\x9c\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $\xe2\x80\xa6'
2020-12-29,b'@pawcio2009 @aaadhikari @factorrules @Amylucio2009 $arwr did this not place?'
2020-12-29,b'New York\xe2\x80\x99s luxury apartment occupancy has come down notably during the COVID-19 pandemic.\n\nAll the data: https://t.co/ec7Zo1dCvQ\n\n#AlternativeData #MachineLearning #ArtificialIntelligence  #RealEstate #Stocks #REO #Foreclosure #Rent #RentRelief $BAM $SPG $LRN $ARWR $UTI $ABEV $KR https://t.co/jDKcQ8wK5o'
2020-12-29,b'RT @UNKNOWNAGNT: Trimmed some $ARWR at $86 last week. One of the first times I\xe2\x80\x99ve sold. Best believe i will be adding more tomorrow.'
2020-12-29,b'Trimmed some $ARWR at $86 last week. One of the first times I\xe2\x80\x99ve sold. Best believe i will be adding more tomorrow.'
2020-12-28,b'$DLOC OVERSOLD! 1 MILLION FLOAT!!!\xf0\x9f\x92\xb8\xf0\x9f\x9b\x92\xf0\x9f\x93\x88\xf0\x9f\x8d\xbe\xe2\x9c\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/p9OF4JavZu'
2020-12-28,b'Overbought 12/24\n$VERB\n$NTAP\n$CLNE\n$ELVT\n$NGM\n$PMVP\n$ERII\n$ESTE\n$RCM\n$ARVN\n$OAC\n$ELYS\n$CPST\n$FTOC\n$DOMO\n$IPV\n$TGTX\n$CRSP\n$HDS\n$EDIT\n$ESTA\n$PRLD\n$LMND\n$PSTG\n$EQS\n$SSYS\n$PACB\n$IRDM\n$ENPH\n$PTC\n$UIS\n$ARWR\n$VBLT\n$COOP\n$RICK\n$RDI\n$DMYD\n$AMSC\n$CGRO\n$TUFN\n$JSD\n$RGLS\n$RILY\n$GV\n$STEP\n$ETTX'
2020-12-28,b'New high 12/24\n$AI\n$ELF\n$BNED\n$TPB\n$ARWR\n$KYMR\n$WLDN\n$RDWR\n$GHLD\n$CFIIU\n$ALVR\n$THRM\n$CAMT\n$MC\n$VECO\n$OMI\n$OSS\n$EVR\n$LFTRU\n$PLXP\n$ORGO\n$BMI\n$INAQ\n$ALRM\n$IRDM\n$TENB\n$CSSE\n$AEYE\n$AAXN\n$BGFV\n$FBC\n$INTZ\n$BOMN\n$NVEE\n$VCEL\n$AIRG\n$CERS\n$ZS\n$VRNS\n$WAL\n$WOW\n$NICE\n$ERII\n$ANSS\n$ECF\n$CDAY'
2020-12-28,b'RT @ArrowheadPharma: At Arrowhead Pharmaceuticals we are expanding our pipeline across multiple tissue types with our RNA interference tech\xe2\x80\xa6'
2020-12-28,b'RT @ArrowheadPharma: At Arrowhead Pharmaceuticals we are expanding our pipeline across multiple tissue types with our RNA interference tech\xe2\x80\xa6'
2020-12-28,b'@HMKWatch @Jon12508683 @semodough ...Also long both $IONS and $ARWR'
2020-12-28,"b'RT @BikeRieder: @Mcdivot06 @ArrowheadPharma $ARWR I expect FDA decision early in Q1. Why? AAT has FastTD, patients need drug. Results coh 1\xe2\x80\xa6'"
2020-12-28,"b'$TKOI OVERSOLD, microscopic float big money loading\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/lbfMVqYawA'"
2020-12-28,b'@Jon12508683 @semodough I\xe2\x80\x99m long all three $IONS $ARWR and $NBSE I don\xe2\x80\x99t understand why so many traders on here get so passionate about one or the other when you can easily own both.'
2020-12-28,b'$WSGF OVERSOLD! the next airbnb\xf0\x9f\x92\xb8 \n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/OwrGvf7h7o'
2020-12-28,b'$UAPC OVERSOLD! next #MARIJUANA STOCK TO FLY\xf0\x9f\x92\xb8\xe2\x9c\x88\xf0\x9f\x93\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/T9KnDbJnqB'
2020-12-28,"b""@Jon12508683 @semodough I hope you haven't given up on $NBSE Big catalysts in 2021 More HD data Q1? Big revelations at R&amp;D day 1H '21. Oncology? Rare disease? Big Pharma/ will be Institutionalized. IND filing/approval for 1 or 2 drugs. Lots of goodies in '21 Going to fly! with new CSO from $ARWR"""
2020-12-27,b'$ARWR Long for the next 2-4 years. Do your own due diligence. Onward and upward.'
2020-12-27,b'$GBTC to take a decision on ratifying forward split for implementation next quarter\nhttps://t.co/aQqxh927Rv\n\n$LTBR $FMCC $HBHC $GWR $HUM $PJET $GVDI $NAK $FCEL $RLJ $GPN $RJF $ARWR $'
2020-12-27,b'RT @Getrealorelse: @mchilberg helpful\xef\xbc\x8cthanks.   I also hold $arwr.   Have similar type of collaborations and wait game feel.'
2020-12-27,b'@mchilberg helpful\xef\xbc\x8cthanks.   I also hold $arwr.   Have similar type of collaborations and wait game feel.'
2020-12-27,b'$DLOC OVERSOLD! 1 MILLION FLOAT!!!\xf0\x9f\x92\xb8\xf0\x9f\x9b\x92\xf0\x9f\x93\x88\xf0\x9f\x8d\xbe\xe2\x9c\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/wTQLeUp2q0'
2020-12-26,b'RT @CompoundNovice: Wait until DNA/ RNA biotechs start branding themselves as Tech companies.\n\nWhat could that do for valuations?\n\nBioinfor\xe2\x80\xa6'
2021-01-07,"b""@pawcio2009 thank you for the list\n\n$PAVM $ONCT $AFMD $SIOX $XAIR $PDSB $ADAP $APTO $CRIS $SGMO $TCON $CYCC $LPTX $KALA $TRIL $NWBO $ANVS $KPTI $MREO $PIRS $TGTX $VBIV $XERS $ARWR $ATNM $BCRX $BNGO $EVFM\n\nhttps://t.co/lMqxB0FAUJ\n\n($NWBO doesn't show)"""
2021-01-07,"b'Comparison between pipeline depth and market cap for mRNA players. $MRNA $BNTX $CVAC $SRPT $IONS $ARWR $ARCT $DRNA $RNA $VYGR. maybe ill breakdown $ALNY later but their pipeline layout is annoying.  If i missed something or made a mistake let me know, and share a screenshot https://t.co/K50z28Gi5S'"
2021-01-07,"b'RT @Steve_382: $ALNY #RNAi The probability of success is so much better than the industry overall. $ARWR $DRNA, etc. https://t.co/IrWbHm9Zka'"
2021-01-07,b'RT @BikeRieder: Exactly @WallStPirate \nWith TRiM $ARWR has succes rate of 100% till today.\nExamples for small molecules? Look at clinical d\xe2\x80\xa6'
2021-01-07,b'Great news for patients and investors this morning \nhttps://t.co/DugRGhrK5m\nLong #RNAiRevolution $ALNY $ARWR $DRNA'
2021-01-07,b'RT @BikeRieder: Exactly @WallStPirate \nWith TRiM $ARWR has succes rate of 100% till today.\nExamples for small molecules? Look at clinical d\xe2\x80\xa6'
2021-01-07,"b'RT @chunfeng0808: Next generation biotech platform leader:\n1) B-Bio-database: $ILMN, $TXG $TWST 13andme; $ADPT\n2) Gene edit: $CRSP $BEAM, $\xe2\x80\xa6'"
2021-01-07,"b'Next generation biotech platform leader:\n1) B-Bio-database: $ILMN, $TXG $TWST 13andme; $ADPT\n2) Gene edit: $CRSP $BEAM, $EDIT, $NTLA\n3) mRNA and siRNA: $mRNA, $BNTX,$CVAC, $TBIO, $ARWR, $ALNY\n4) Gene therapy: $FOLD, $RGNX, $GBIO;'"
2021-01-07,"b'RT @Steve_382: $ALNY #RNAi The probability of success is so much better than the industry overall. $ARWR $DRNA, etc. https://t.co/IrWbHm9Zka'"
2021-01-07,"b'RT @Steve_382: $ALNY #RNAi The probability of success is so much better than the industry overall. $ARWR $DRNA, etc. https://t.co/IrWbHm9Zka'"
2021-01-07,"b'RT @Steve_382: $ALNY #RNAi The probability of success is so much better than the industry overall. $ARWR $DRNA, etc. https://t.co/IrWbHm9Zka'"
2021-01-07,"b'$ALNY #RNAi The probability of success is so much better than the industry overall. $ARWR $DRNA, etc. https://t.co/IrWbHm9Zka'"
2021-01-07,"b""Rose Above Previous Day's High today: $AMOM $SNOW $BIO $PRGO $COO $PEN $HAE $ABC $NBIX $CMCO $KURA $ARWR $CDNA $RVNC $RCKT $ALKS $HZNP $REPL $ALLO $IUSV ... https://t.co/TBYRpvrFqi"""
2021-01-07,"b'Sold 0.1k $ARWR at $78.73, now 4.7k #vssporte shares.'"
2021-01-07,"b'Sold 0.1k $ARWR at $78.655, now 4.8k #vssporte shares.'"
2021-01-07,"b'RT @jfais20: $XBI $IBB To gain exposure to a particular theme or class of drugs, a \xc2\xa8basket approach\xc2\xa8 is often optimal (balances diversifica\xe2\x80\xa6'"
2021-01-07,"b'Sold 0.1k $ARWR at $78.37, now 4.9k #vssporte shares.'"
2021-01-07,"b'Sold 0.6k $ARWR at $77.99, now 5.0k #vssporte shares.'"
2021-01-07,"b'Sold 0.4k $ARWR at $77.5899, now 5.6k #vssporte shares.'"
2021-01-07,"b'$XBI $IBB To gain exposure to a particular theme or class of drugs, a \xc2\xa8basket approach\xc2\xa8 is often optimal (balances diversification, risk and upside)\n\nie equal parts $ALXO $TRIL in CD47\n\n$ARWR $DRNA $ALNY in RNAi\n\nWhat others come to mind for you?'"
2021-01-07,b'@jonesallen234 ALNY &amp; VIR testing 350 siRNAs for COVID viruses shows the superior bioinformatics employed by $ARWR and why Arrowhead will beat them to the marketplace in most indications.\nSpeed and efficacy will overwhelm the competition!'
2021-01-07,"b""RT @WallStPirate: $ARWR  ALNY announced good results for their ATTR amyloidosis this morning.  This is great for all RNAi co's as word spre\xe2\x80\xa6"""
2021-01-07,"b'RT @StockConsultant: $ARWR Arrowhead Pharmaceuticals stock back to 73.62 support area with bullish stats , stocks #StockToWatch https://t.c\xe2\x80\xa6'"
2021-01-07,"b'$ARWR Arrowhead Pharmaceuticals stock back to 73.62 support area with bullish stats , stocks #StockToWatch https://t.co/sjC6radwTv'"
2021-01-07,"b'RT @Tickeron: $ARWR enters a Downtrend as Momentum Indicator dropped below the 0 level on December 31, 2020. View odds for this and other i\xe2\x80\xa6'"
2021-01-07,"b'$ARWR enters a Downtrend as Momentum Indicator dropped below the 0 level on December 31, 2020. View odds for this and other indicators: https://t.co/q0HokVgBA7 #ArrowheadPharmaceuticals #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/c0jBISAkOS'"
2021-01-07,"b'RT @KirkGossett: Any ""mention"" of a positive proof of concept for the 3 clinical programs launched in 2020 (HSD, ENaC or HIF2) could be exp\xe2\x80\xa6'"
2021-01-07,"b'RT @jfais20: $ARWR AAT economics weren\'t ""partnered away"", they retained 50/50 US split (20-25% royalties ex) and linked up w/top tier phar\xe2\x80\xa6'"
2021-01-07,b'RT @MichaelMeltzer1: $ARWR The ultimate gift with ARWR down this much on no negative news and no need for financing. Added to my overloaded\xe2\x80\xa6'
2021-01-07,b'RT @fpscod9: $ARWR\nI still remember the good old days when 0.3 mil was a nice volume.\nNowadays is 1 to 2 million at 10 times higher price.\xe2\x80\xa6'
2021-01-07,"b'RT @WallStPirate: $ARWR   Coming up on month 6 for the first patient dosed for HIF2.  No safety issues announced, lets hope these patients\xe2\x80\xa6'"
2021-01-07,b'RT @jonesallen234: RNAi has an inherent advantage by not using LNP in their therapies $ALNY $ARWR $DRNA\nhttps://t.co/Dg2Zv3pycc'
2021-01-07,b'RNAi has an inherent advantage by not using LNP in their therapies $ALNY $ARWR $DRNA\nhttps://t.co/Dg2Zv3pycc'
2021-01-07,b'Exactly @WallStPirate \nWith TRiM $ARWR has succes rate of 100% till today.\nExamples for small molecules? Look at clinical dev success rate 2006-2015 - from Biotech Innovation Organization (n = 9985!) https://t.co/oYcLrryEPw https://t.co/teJn6iGxrf'
2021-01-07,"b""$ARWR  ALNY announced good results for their ATTR amyloidosis this morning.  This is great for all RNAi co's as word spreads about safety, efficacy and high success rate from preclinical to P3 of over 50% while small molecule is at 5% success."""
2021-01-07,b'$ARWR might hit \xc2\xa0$81.82 \xc2\xa0soon 2.41 % change recently. https://t.co/skWXzorhUp'
2021-01-07,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nInsider\n\nJAMES C HAMILTON:\n\nhttps://t.co/rS0AbBNGAA"""
2021-01-07,b'$ARWR I am gona keep buying until it hits $81.86 dollars  2.46 % change  https://t.co/skWXzorhUp'
2021-01-07,b'$ARWR Enjoy the weekend everyone! Cheers! \xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd -2.94 % change recently https://t.co/CN8iOvf2Pt'
2021-01-07,b'RT @commandenteSD: Dr. High at the close. \n$SHOO \n$MSTR\n$POOL\n$STRO\n$HAE\n$BLDR\n$CBOE\n$ARWR https://t.co/96vsrXxwoR'
2021-01-07,b'RT @commandenteSD: Dr. High at the close. \n$SHOO \n$MSTR\n$POOL\n$STRO\n$HAE\n$BLDR\n$CBOE\n$ARWR https://t.co/96vsrXxwoR'
2021-01-07,"b""$ARWR Want to sell this stock, but don't want to sell while it's down  -2.94 % change recently https://t.co/KziCeCzPpm"""
2021-01-07,"b'@pt117cool ""You know who"" (for those following along) = ""The Mighty Arrow"" $ARWR, my oldest and biggest $ holding!'"
2021-01-07,b'Dr. High at the close. \n$SHOO \n$MSTR\n$POOL\n$STRO\n$HAE\n$BLDR\n$CBOE\n$ARWR https://t.co/96vsrXxwoR'
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nGeneral Counsel\n\nPATRICK O'BRIEN:\n\nhttps://t.co/iJqmgIF9eN"""
2021-01-06,"b'@pt117cool It\'s you @pt117cool but I am surprised you have not been Following all along!  Fellow ""Brother-in- $ARWR-arms"".  You win a free subscription to @MarketTrendAdv picks.  Only catch is it is free to everyone!  Bests!'"
2021-01-06,"b""OK, who's going to be my lucky 500th?? \xf0\x9f\x98\x9d\n$ARBKF $ARWR $APPN $BTC $CLSK $CWH $ENG $KOD $OSTK $RVN https://t.co/VIHyMcZlOx"""
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nInsider\n\nJAMES C HAMILTON:\n\nhttps://t.co/rS0AbBw5c0"""
2021-01-06,b'RT @derivedfromdata: New York\xe2\x80\x99s luxury #apartment occupancy has come down notably during the #COVID19 #pandemic.\n\nMore analysis: https://t.\xe2\x80\xa6'
2021-01-06,b'New York\xe2\x80\x99s luxury #apartment occupancy has come down notably during the #COVID19 #pandemic.\n\nMore analysis: https://t.co/ec7Zo0W1Ei\n\n#AlternativeData #MachineLearning #ArtificialIntelligence  #RealEstate #Stocks #REO #Foreclosure #Rent #RentRelief $BAM $SPG $LRN $ARWR $UTI $ABEV https://t.co/8Jfj6k0ku0'
2021-01-06,"b'$ARWR   Coming up on month 6 for the first patient dosed for HIF2.  No safety issues announced, lets hope these patients are still living as they were all late stage 3 &amp; 4 RCC. Remember the mice that were dosed all lived and tumors shrunk non dosed mice died.'"
2021-01-06,b'$ARWR Retest of the VWAP and go. https://t.co/r4cP2iWUdz'
2021-01-06,b'$ARWR Volume Speaks \xf0\x9f\x98\xa4'
2021-01-06,b'$ARWR\nI still remember the good old days when 0.3 mil was a nice volume.\nNowadays is 1 to 2 million at 10 times higher price.\n$ARWR FTW !'
2021-01-06,"b'Large Print $ARWR Size: 122554 Price: 74.38 Time: 1600 Amount: $9,115,566.52'"
2021-01-06,b'@Biotech2k1 I would start with RNAi companies - ARK does not hold a single one in its funds - $ALNY $DRNA $ARWR $SLN'
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nInsider\n\nJAMES C HAMILTON:\n\nhttps://t.co/rS0AbBNGAA"""
2021-01-06,"b""Rose Above Previous Day's High today: $RMM $PDSB $NHS $DARE $AAIC $TWCTU $ACTG $ASPS $API $BB $KRTX $TH $ICUI $MGEN $ARWR $IDU $SQNS $ASND $FRGI $AIW ... https://t.co/TBYRpvrFqi"""
2021-01-06,"b'@ronwichgers @TrendSpider $arwr trying to set up a nice ""railroad tracks"" reversal in here.'"
2021-01-06,b'RT @BikeRieder: $ARWR Good volume !'
2021-01-06,b'RT @BikeRieder: $ARWR Good volume !'
2021-01-06,b'$ARWR Good volume !'
2021-01-06,b'RT @biostonks: A list of mRNA players $MRNS $BNTX $ALNY $CVAC $SRPT $CRSP $IONS $ARWR $NTLA $ARTC $DRNA $TBIO $RNA $DTLA $SLN $HOOK $ABUS $\xe2\x80\xa6'
2021-01-06,"b'A list of mRNA players $MRNS $BNTX $ALNY $CVAC $SRPT $CRSP $IONS $ARWR $NTLA $ARTC $DRNA $TBIO $RNA $DTLA $SLN $HOOK $ABUS $VYGR $PRQR $ELOX $XCUR $BNTC if you want one added provide a link so I can read it, thanks https://t.co/mdFwZzwGjb'"
2021-01-06,b'RT @timothysykes: Retweet/favorite this for a video lesson detailing how I made roughly $4k today on $DPWW thanks to @sttbreakingnews naili\xe2\x80\xa6'
2021-01-06,b'Finally som green \xf0\x9f\x98\x85 $ARWR https://t.co/7oO2epP2b6'
2021-01-06,b'$ISR MASSIVE BUYS AFTERHOURS BOUNCING. $3 BREAK SOON\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $F https://t.co/dfy8gbIY1u'
2021-01-06,"b'RT @malteseinvest: $ARWR \nBought @ 43.45 - Stop Profit raised to 69.90 \nTarget 98.46, 118.20, 124.45 \n\nFirst failure to close above the TL\xe2\x80\xa6'"
2021-01-06,"b'RT @malteseinvest: $ARWR \nBought @ 43.45 - Stop Profit @ 69.90 \nTarget 98.46, 118.20, 124.45 \n\nBreaking down lower, control @ 73.76 needs t\xe2\x80\xa6'"
2021-01-06,b'$ARWR in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/YQdAlHylWH #ArrowheadPharmaceuticals #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CIA0uSNkU1'
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nDirector\n\nDOUGLAS B GIVEN:\n\nhttps://t.co/RfRBBDm6fc"""
2021-01-06,"b""RT @BikeRieder: $ARWR Baird triggered it. Some BO chatter. If, than I don't see AMGN but $JNJ. Not BO, but a Roche/Genentech typ of deal (1\xe2\x80\xa6"""
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nDirector\n\nMICHAEL S PERRY:\n\nhttps://t.co/HEH35yZUV5"""
2021-01-06,"b'RT @malteseinvest: $ARWR \nBought @ 43.45 - Stop Profit @ 69.90 \nTarget 98.46, 118.20, 124.45 \n\nBreaking down lower, control @ 73.76 needs t\xe2\x80\xa6'"
2021-01-06,"b""$ARWR Baird triggered it. Some BO chatter. If, than I don't see AMGN but $JNJ. Not BO, but a Roche/Genentech typ of deal (1990). Roche got a majority stake. Here I only see a minority stake deal. ARWR will stay independent. JNJ1-3 are ready to option in. THE Moment  @Mcdivot06"""
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nChief Financial Officer\n\nKENNETH ALLEN MYSZKOWSKI:\n\nhttps://t.co/Lsjrkwgr0c"""
2021-01-06,"b""$ARWR:\n\nNew Insider Filing on ARROWHEAD PHARMACEUTICALS, INC.'s\n\nDirector\n\nWILLIAM D. WADDILL:\n\nhttps://t.co/rCsEWWYXnY"""
2021-01-06,b'Preference given by me to 1 Super Disruptive Biotech Stock With Solid Long-Term Potential...that being $ARWR Arrowhead Pharma!'
2021-01-06,b'$ARWR significant stock price movement  -2.48 % change recently https://t.co/skWXzorhUp'
2021-01-06,"b'$ARWR - Coldlander1 hour ago\nA lot of form 4s filed tonight. Here is the skinny:\nMichael Perry - Acquired 9,000 Sold 4,000\nMauro Ferrari - Acquired 9,000 Sold 0\nJames Hamilton - Acquired 50,000 Sold 0\nMarianne De Backer - Acquired 9,000 Sold 0'"
